# Open-label Investigation of the Safety and Clinical Effects of NTCELL in Patients With Parkinson's Disease

> **NCT01734733** · PHASE1,PHASE2 · COMPLETED · sponsor: **Living Cell Technologies** · enrollment: 4 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **OTHER:** NTCELL

## Key facts

- **NCT ID:** NCT01734733
- **Lead sponsor:** Living Cell Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-12
- **Primary completion:** 2015-06-04
- **Final completion:** 2020-06-04
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2020-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01734733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01734733, "Open-label Investigation of the Safety and Clinical Effects of NTCELL in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01734733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*